Hepatitis C type 2A treatment options include interferon combined with ribavirin, oral direct antiviral medication + interferon combined with ribavirin, and all oral direct antiviral medication. The specific treatment options chosen are further examined through the hospital and selected according to the doctor’s recommendation. 1. Interferon combined with ribavirin: This is the treatment of hepatitis C with pegylated interferon and ribavirin. If interferon is used alone, the sustained virologic response rate is low. In combination with ribavirin, the sustained virologic response rate increases significantly. 2. Oral direct antiviral drugs + interferon combined with ribavirin treatment: refers to the treatment of hepatitis C with oral direct antiviral drugs, combined with interferon and ribavirin, which can increase the sustained virological response rate of monotherapy by up to 75%. 3. Oral direct antiviral therapy: refers to the method of treating hepatitis C by taking oral direct antiviral drugs only, without combining with other drugs. The representative drug is Sofosbuvir, which cannot be combined with interferon and is not easy to produce drug resistance. Therefore, the choice of hepatitis C type 2A treatment drugs should be under the guidance of the doctor to choose the most reasonable treatment program, including the dose and the duration of medication, so as to achieve early detection and early treatment.